Filing Details

Accession Number:
0001209191-10-046526
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2010-09-16 14:36:05
Reporting Period:
2010-08-13
Filing Date:
2010-09-16
Accepted Time:
2010-09-16 14:36:05
Original Submission Date:
2010-08-23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093649 Idenix Pharmaceuticals Inc IDIX Pharmaceutical Preparations (2834) 450478605
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1030617 Ag Pharma Novartis Lichstrasse 35
Basel V8 Ch 4002
No No Yes Yes
1114448 Ag Novartis Lichstrasse 35
Basel V8 CH 4002
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-08-13 36,048 $2.41 31,360,235 No 4 P Indirect See footnote
Common Stock Acquisiton 2010-08-13 262 $2.96 31,360,497 No 4 P Indirect See footnote
Common Stock Acquisiton 2010-08-13 91 $3.04 31,360,588 No 4 P Indirect See footnote
Common Stock Acquisiton 2010-08-13 813 $3.79 31,361,401 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG. Novartis AG is an indirect beneficial owner of these securities. See attachment.